MycoBiomDB – Record Details (MyCo_1311)

Biomarker Record Details

Database ID: MyCo_1311
DB IDMyCo_1311
TitleAccuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis
Year2012
PMID22329494
Fungal Diseases involvedPneumocystis jirovecii pneumonia
Associated Medical ConditionNone
GenusPneumocystis
Speciesjirovecii
OrganismPneumocystis jirovecii
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameBDG
Biomarker Full Name1-3-beta-D-Glucan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationUSA
CohortBDG data were analysed for 357 PCP cases and 1723 controls.
Cohort No.357 Patients and 1723 control
Age GroupNone
P ValueNone
Sensitivity0.948
Specificity0.863
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismPneumocystis jirovecii pneumonia (PCP) is a common and potentially serious opportunistic infection affecting patients with immunosuppression due to various conditions. Such conditions include infection with human immunodeficiency virus (HIV), as well as haematological malignancies, solid organ transplantation, solid tumours, and treatment with cer-tain immunosuppressive agents [1].Although PCP often has a characteristic clinical presentation with fever, dry cough, dyspnoea, hypoxia and diffuse ground glass opacities in the chest X-ray, the differential diagnosis of pulmonary infiltrates in patients with immunosuppression is broad.
TechniqueBioinformatics analysis
Analysis MethodBivariate meta-analysis
ELISA kitsNone
Assay DataNone
Validation Techniques usedBivariate meta-analysis
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone